Retroviral gene transduction of adult peripheral blood or marrow- derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo

Blood

Volumn 89, Issue 11, 1997, Pages 4040-4046

  Emmons, R V B ^a   Doren, S ^b   Zujewski, J ^b   Cottier Fox, M ^b   Carter, C S ^b   Hines, K ^b   O'Shaughnessy, J A ^b   Leitman, S F ^b   Greenblatt, J J ^b   Cowan, K ^b   Dunbar, C E ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; COLONY STIMULATING FACTOR; CYCLOPHOSPHAMIDE; GROWTH FACTOR; INTERLEUKIN 3; INTERLEUKIN 6;

ARTICLE; BONE MARROW; COLONY FORMING UNIT; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS; SIGNAL TRANSDUCTION; VIRUS GENE;

EID: 0030965964     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.11.4040     Document Type: Article

References (30)

1. Dunbar CE, Emmons RVB: Gene transfer into hematopoietic progenitor and stem cells: Progress and problems. Stem Cells 12:563, 1994
2. Karlsson S: Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 78:2481, 1991
3. Mulligan RC: The basic science of gene therapy. Science 260:926, 1993
4. Dunbar CE, Cottier-Fox M, O'Shaughnessy JA, Doren S, Carter CS, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson W, Cowan KH, Young NS, Nienhuis AW: Retrovirally-marked CD34-enriched peripheral blood and bone marrow and cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
5. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
6. Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW: Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture initiating cells. Blood 79:1393, 1992
7. Carter RF, Abrams-Ogg ACG, Dick JE, Kruth SA, Valli VE, Kamel-Reid S, Dube ID: Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 79:356, 1992
8. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451, 1994
9. Dunbar CE, Nienhuis AW, Stewart FM, Quesenberry P, O'Shaughnessy J, Cowan K, Cottier-Fox M, Leitman S, Goodman S, Sorrentino BP: Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer. Hum Gene Ther 4:205, 1993
10. Cornetta K, Morgan RA, Anderson WF: Safety issues related to retroviral-mediated gene transfer to humans. Hum Gene Ther 2:5, 1991
11. Cottier-Fox M, Cipolone K, Berenson R, O'Shaughnessy J, Dunbar C: Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation. Exp Hematol 23:230, 1995
12. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
13. Vescio RA, Hong CH, Cao J, Kirn A, Schiller GJ, Lichtenslein AK, Berenson RJ, Berenson JR: The hematopoietic slem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 84:3283, 1994
14. Cassel A, Cotller-Fox M, Doren S, Dunbar CE: Retroviralmediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol 21:585, 1993
15. von Kalle C, Kiem HP, Goehle S, Darovsky B, Heimfeld S, Torok-Storb B, Storb R, Schuening FG: Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood 84:2890, 1994
16. Brenner MK: The contribution of marker gene studies to hemopoietic stem cell therapies. Stem Cells (Dayt) 13:453, 1995
17. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
18. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470, 1995
19. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
20. Dunbar CE, Seidel NE, Doren S, Sellers S, Cline A, Metzger M, Agricola B, Donahue R, Bodine D: Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 93:11871, 1996
21. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD: T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 2:216, 1996
22. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2:545, 1996
23. von Melchner H, Housman DE: The expression of neomycin phosphotransferase in human promyelocytic leukemia cells (HL60) delays their differentiation. Oncogene 2:137, 1988
24. Cornetta K, Srour EF, Moore A, Davidson A, Broun ER, Hromas R, Moen RC, Morgan RA, Rubin L, Anderson WF, Hoffman R, Tricot G: Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia. Hum Gene Ther 7:1323, 1996
25. Stewart AK, Dube ID, Kamel-Reid S, Keating A: A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma. Hum Gene Ther 6:107, 1995
26. + bone marrow cells. Blood 82:1975, 1993
27. O'Shaughnessy JA, Cowan KH, Wilson W, Bryant G, Gold-spiel B, Gress R, Nienhuis AW, Dunbar C, Sorrentino B, Stewart FM: Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer. Hum Gene Ther 4:331, 1993
28. Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli M, Schera M, Zallone AZ, Marchisio PC: Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 77:2688, 1991
29. Bjsrkstrand B, Dilber MS, Smith CIE, Gahrton G, Xanthopoulos KG: Retroviral-mediated gene transfer into human myeloma cells. Br J Haematol 88:325, 1994
30. Nolta JA, Smogorzewska EM, Kohn DB: Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101, 1995